Immune Design Corp.

(IMDZ) Trade

By |

Profile

Immune Design is a clinical-stage immunotherapy company. Its focus is next-generation in vivo methods intended to enable the body's immune system to fight diseases. The company's therapies have a broad potential approach across multiple therapeutic areas. Nevertheless, the company's target is oncology, and it is developing tumor-specific cytotoxic T cells to fight cancer. The main discoveries are CMB305 and G100, immuno-oncology approaches that are believed to address the shortcomings of existing oncological therapies.

Contact Information

Website: www.immunedesign.com
Email: sylvia.wheeler@immunedesign.com
Main Phone: +1 206 682-0645
Address: 1616 Eastlake Avenue East
Address 2: Suite 310
State: WA
City / Town: Seattle
Country: USA
Postal Code: 98102

Issuer Information

Exchange: NSD
CEO: Carlos V. Paya
Employees: 56
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.01 $ 0.17 (9.24%)
Last Price 2.01 Change $ 0.17 Change % 9.24 Tick N/A
Bid 2.00 Bid Size 1,500.00 Ask 2.05 Ask Size 1,500.00
Open 1.85 High 2.07 Low 1.79 Prev Close 1.84
Last Trade Volume 1.3 mi 52 Wk Hi 5.05 52 Wk Low 1.25
Market Cap 96.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 48,164,828.00 EPS (TTM) -1.05 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 32
Number of Buys 0 24
Number of Sells 0 8
Net Activity 0 5487055
Last 10 Buys Shares
Leo A. Guthart 1,000
Lewis W. Coleman 1,000
Franklin M. Berger 1,000
Peter Svennilson 1,000
Lewis W. Coleman 1,000
Leo A. Guthart 1,000
Franklin M. Berger 1,000
Leo A. Guthart 1,000
Leo A. Guthart 1,000
Leo A. Guthart 1,000
Last 10 Sell Shares
Sergey Yurasov 1,000
Wayne R. Gombotz 1,000
Carlos V. Paya 1,000
Jan Henrik Ter Meulen 1,000
Stephen R. Brady 1,000
Wayne R. Gombotz 1,000
Wayne R. Gombotz 1,000
Jan Henrik Ter Meulen 1,000
Stephen R. Brady 1,000
Carlos V. Paya 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 11.5 11.5 11.5 11.5
Standard Deviation 5.74 5.74 5.74 5.74
Date of Most Recent Estimate 05/29/18 05/03/18 05/03/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.6 1.6 1.6 1.6